Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Nov-24 10:00 PM View:  | Beskrovnaya Oxana Chief Scientific Officer | Dyne Therapeutics, Inc. (DYN) | 18-Nov-24 | Private Sale (Planned) | 2,856 | $28.20 | $80,539.20 | (2%) 140.38K to 137.52K | |
| 18-Nov-24 7:42 PM View: | Incerti Carlo Director | Dyne Therapeutics, Inc. (DYN) | 18-Nov-24 | Option Exercise | 16,500 | $8.69 | $143,385.00 | 100% 0 to 16.5K | |
| 18-Nov-24 7:42 PM View: | Incerti Carlo Director | Dyne Therapeutics, Inc. (DYN) | 18-Nov-24 | Option Sale | 16,500 | $28.73 | $474,045.00 | (100%) 16.5K to 0 | |
| 15-Nov-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 14-Nov-24 | Sale | 8,929 | $32.82 | $293,050.00 | (< 1%) 5.86M to 5.85M | |
| 18-Nov-24 5:31 PM View: | Rhodes Jason P Director | Dyne Therapeutics, Inc. (DYN) | 14-Nov-24 | Private Sale | 782 | $33.10 | $25,884.20 | (< 1%) 8.02M to 8.02M | |
| 15-Nov-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 13-Nov-24 | Private Sale (Planned) | 10,803 | $35.24 | $380,698.00 | (< 1%) 5.87M to 5.86M | |
| 03-Oct-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 02-Oct-24 | Sale (Planned) | 21,518 | $35.38 | $761,307.00 | (< 1%) 5.95M to 5.92M | |
| 03-Oct-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 01-Oct-24 | Private Sale (Planned) | 8,423 | $35.16 | $296,153.00 | (< 1%) 5.95M to 5.95M | |
| 01-Oct-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 30-Sep-24 | Sale (Planned) | 30,942 | $35.50 | $1,098,580.00 | (< 1%) 5.99M to 5.95M | |
| 01-Oct-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 27-Sep-24 | Private Sale (Planned) | 32 | $35.00 | $1,120.00 | (< 1%) 5.99M to 5.99M | |
| 27-Sep-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 26-Sep-24 | Sale (Planned) | 1,260 | $35.29 | $44,465.40 | (< 1%) 5.99M to 5.99M | |
| 27-Sep-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 25-Sep-24 | Private Sale (Planned) | 2,357 | $35.06 | $82,636.40 | (< 1%) 5.99M to 5.99M | |
| 24-Sep-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 23-Sep-24 | Sale (Planned) | 40,831 | $35.32 | $1,442,100.00 | (< 1%) 6.03M to 5.99M | |
| 24-Sep-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 20-Sep-24 | Private Sale (Planned) | 79,411 | $36.45 | $2,894,790.00 | (1%) 6.11M to 6.03M | |
| 20-Sep-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 19-Sep-24 | Sale (Planned) | 78,739 | $36.17 | $2,848,280.00 | (1%) 6.19M to 6.11M | |
| 19-Sep-24 4:52 PM View: | Scalzo Richard William SVP, Head of Finance & Admin. | Dyne Therapeutics, Inc. (DYN) | 18-Sep-24 | Private Sale (Planned) | 1,390 | $34.55 | $48,024.50 | (1%) 99.96K to 98.57K | |
| 20-Sep-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 18-Sep-24 | Private Sale (Planned) | 1,554 | $35.03 | $54,436.60 | (< 1%) 6.19M to 6.19M | |
| 19-Sep-24 4:52 PM View: | High Susanna Gatti Chief Operating Officer | Dyne Therapeutics, Inc. (DYN) | 18-Sep-24 | Private Sale (Planned) | 8,976 | $34.41 | $308,864.00 | (6%) 140.61K to 131.64K | |
| 19-Sep-24 4:51 PM View: | Beskrovnaya Oxana Chief Scientific Officer | Dyne Therapeutics, Inc. (DYN) | 18-Sep-24 | Private Sale (Planned) | 2,339 | $34.55 | $80,812.40 | (2%) 142.71K to 140.38K | |
| 18-Sep-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 17-Sep-24 | Sale (Planned) | 3,272 | $35.13 | $114,945.00 | (< 1%) 6.19M to 6.19M | |
| 18-Sep-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 16-Sep-24 | Private Sale (Planned) | 1,320 | $35.04 | $46,252.80 | (< 1%) 6.19M to 6.19M | |
| 11-Sep-24 4:13 PM View: | High Susanna Gatti Chief Operating Officer | Dyne Therapeutics, Inc. (DYN) | 11-Sep-24 | Private Sale (Planned) | 5,270 | $31.89 | $168,060.00 | (4%) 145.88K to 140.61K | |
| 11-Sep-24 4:13 PM View: | Beskrovnaya Oxana Chief Scientific Officer | Dyne Therapeutics, Inc. (DYN) | 11-Sep-24 | Private Sale (Planned) | 2,161 | $31.89 | $68,914.30 | (1%) 144.88K to 142.71K | |
| 11-Sep-24 4:13 PM View: | Scalzo Richard William SVP, Head of Finance & Admin. | Dyne Therapeutics, Inc. (DYN) | 11-Sep-24 | Private Sale (Planned) | 1,468 | $31.89 | $46,814.50 | (1%) 101.43K to 99.96K | |
| 10-Sep-24 4:05 PM View: | Scalzo Richard William SVP, Head of Finance & Admin. | Dyne Therapeutics, Inc. (DYN) | 06-Sep-24 | Option Sale | 116,478 | $32.15 | $3,744,370.00 | (51%) 227.5K to 111.02K | |
| 10-Sep-24 4:05 PM View: | Scalzo Richard William SVP, Head of Finance & Admin. | Dyne Therapeutics, Inc. (DYN) | 06-Sep-24 | Sale | 9,596 | $32.15 | $308,479.00 | (9%) 111.02K to 101.43K | |
| 10-Sep-24 4:05 PM View: | Scalzo Richard William SVP, Head of Finance & Admin. | Dyne Therapeutics, Inc. (DYN) | 06-Sep-24 | Option Exercise | 116,478 | $12.56 | $1,463,380.00 | 105% 111.02K to 227.5K | |
| 09-Sep-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 05-Sep-24 | Private Sale (Planned) | 1,577 | $35.03 | $55,242.30 | (< 1%) 6.2M to 6.19M | |
| 04-Sep-24 5:42 PM View: | Cox John CEO & President Director | Dyne Therapeutics, Inc. (DYN) | 04-Sep-24 | Purchase | 32,000 | $33.04 | $1,057,220.00 | 640% 5.0K to 37.0K | |
| 03-Sep-24 6:16 PM View: | Friedl-Naderer Johanna Chief Commercial Officer | Dyne Therapeutics, Inc. (DYN) | 03-Sep-24 | Grant | 58,400 | -- | -- | 100% 0 to 58.4K | |
| 03-Sep-24 6:22 PM View: | Kerr Douglas Chief Medical Officer | Dyne Therapeutics, Inc. (DYN) | 03-Sep-24 | Grant | 47,500 | -- | -- | 100% 0 to 47.5K | |
| 04-Sep-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 30-Aug-24 | Private Sale (Planned) | 31,300 | $45.59 | $1,427,060.00 | (< 1%) 6.23M to 6.2M | |
| 30-Aug-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 29-Aug-24 | Sale (Planned) | 56,408 | $45.31 | $2,555,750.00 | (< 1%) 6.28M to 6.23M | |
| 30-Aug-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 28-Aug-24 | Private Sale (Planned) | 77,853 | $44.83 | $3,490,030.00 | (1%) 6.36M to 6.28M | |
| 28-Aug-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 27-Aug-24 | Sale (Planned) | 65,403 | $44.28 | $2,896,040.00 | (1%) 6.43M to 6.36M | |
| 28-Aug-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 26-Aug-24 | Private Sale (Planned) | 89,497 | $45.30 | $4,054,410.00 | (1%) 6.52M to 6.43M | |
| 26-Aug-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 23-Aug-24 | Sale (Planned) | 85,088 | $46.23 | $3,934,000.00 | (1%) 6.6M to 6.52M | |
| 26-Aug-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 22-Aug-24 | Private Sale (Planned) | 95,321 | $45.83 | $4,368,080.00 | (1%) 6.7M to 6.6M | |
| 22-Aug-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 21-Aug-24 | Sale (Planned) | 135,763 | $46.78 | $6,350,600.00 | (2%) 6.83M to 6.7M | |
| 22-Aug-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 20-Aug-24 | Private Sale (Planned) | 86,840 | $46.35 | $4,025,020.00 | (1%) 6.92M to 6.83M | |
| 20-Aug-24 4:26 PM View: | Beskrovnaya Oxana Chief Scientific Officer | Dyne Therapeutics, Inc. (DYN) | 19-Aug-24 | Private Sale (Planned) | 2,636 | $45.12 | $118,939.00 | (2%) 147.51K to 144.88K | |
| 20-Aug-24 4:28 PM View: | Scalzo Richard William SVP, Head of Finance & Admin. | Dyne Therapeutics, Inc. (DYN) | 19-Aug-24 | Private Sale (Planned) | 2,752 | $45.12 | $124,174.00 | (2%) 113.77K to 111.02K | |
| 20-Aug-24 4:26 PM View: | High Susanna Gatti Chief Operating Officer | Dyne Therapeutics, Inc. (DYN) | 19-Aug-24 | Private Sale (Planned) | 2,910 | $45.12 | $131,304.00 | (2%) 148.79K to 145.88K | |
| 20-Aug-24 4:27 PM View: | McNeill Jonathan Chief Business Officer | Dyne Therapeutics, Inc. (DYN) | 19-Aug-24 | Private Sale (Planned) | 2,705 | $45.12 | $122,054.00 | (2%) 134.81K to 132.11K | |
| 20-Aug-24 4:27 PM View: | Farwell Wildon Chief Medical Officer | Dyne Therapeutics, Inc. (DYN) | 19-Aug-24 | Private Sale (Planned) | 2,321 | $45.12 | $104,727.00 | (2%) 145.54K to 143.22K | |
| 20-Aug-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 19-Aug-24 | Sale (Planned) | 126,032 | $45.82 | $5,774,370.00 | (2%) 7.04M to 6.92M | |
| 20-Aug-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 16-Aug-24 | Private Sale (Planned) | 122,643 | $45.14 | $5,535,820.00 | (2%) 7.17M to 7.04M | |
| 16-Aug-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 15-Aug-24 | Sale (Planned) | 180,891 | $45.37 | $8,206,150.00 | (2%) 7.35M to 7.17M | |
| 16-Aug-24 4:05 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 14-Aug-24 | Private Sale (Planned) | 100,650 | $43.67 | $4,395,390.00 | (1%) 7.45M to 7.35M | |
| 14-Aug-24 4:15 PM View: | Kersten Dirk Director | Dyne Therapeutics, Inc. (DYN) | 13-Aug-24 | Sale (Planned) | 133,985 | $42.78 | $5,731,740.00 | (2%) 7.58M to 7.45M |
